32476-67-8
Chemical Structure
Periplocymarin
- CAS. Nr.: 32476-67-8
- Formula:C30H46O8
- Molecular Weight:534.68
IUPAC Name: 4-((3S,5S,8R,9S,10R,13R,14S,17R)-5,14-dihydroxy-3-(((2R,4S,5R,6R)-5-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one
InChIKey: XRWQBDJPMXRDOQ-YUUDFPFBSA-N
SMILES: O[C@@]12[C@@]3([H])[C@@](CC[C@@]1([C@@H](C4=CC(OC4)=O)CC2)C)([H])[C@@]5([C@@](O)(C[C@@H](O[C@@]6([H])C[C@@H]([C@H](O)[C@@H](C)O6)OC)CC5)CC3)C
Biological Activity: Periplocymarin, a cardiac glycoside isolated from Periploca sepium and Periploca graeca, is a potential anti-cancer compound[1][2].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Periplocymarin | 99.90% | Periplocymarin, a cardiac glycoside isolated from Periploca sepium and Periploca graeca, is a potential anti-cancer compound. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.88
HY-111934Cymarin -
Similarity Score 0.85
HY-N7496Odoroside A -
Similarity Score 0.82
HY-N12520Helveticoside -
Similarity Score 0.82
HY-N27788-Hydroxyodoroside A -
Similarity Score 0.81
HY-N1381RPeriplocin (Standard) -
Similarity Score 0.81
![Periplogenin 3-[O-β-glucopyranosyl-(1→4)-β-sarmentopyranoside] Chemical Structure](//file.medchemexpress.com/product_pic/hy-n5053.gif)
HY-N5053Periplogenin 3-[O-β-glucopyranosyl-(1→4)-β-sarmentopyranoside] -
Similarity Score 0.81
HY-N9208Sarmentocymarin -
Similarity Score 0.77
HY-N1106Uzarigenin digitaloside -
Similarity Score 0.77
HY-N19944Odoroside -
Explore the MedChemAI to find more analogs
![Periplogenin 3-[O-β-glucopyranosyl-(1→4)-β-sarmentopyranoside] Chemical Structure](http://file.medchemexpress.com/product_pic/hy-n5053.gif)
References
- [1]. Martey ON, et al. Periplocymarin is a potential natural compound for drug development: highly permeable with absence of P-glycoprotein efflux and cytochrome P450 inhibitions. Biopharm Drug Dispos. 2014 May;35(4):195-206. [Content Brief]
- [2]. Redox-responsive PEGylated self-assembled prodrug-nanoparticles formed by single disulfidebond bridge periplocymarin-vitamin E conjugate for liver cancer chemotherapy. Drug Deliv. 2017 Nov;24(1):1170-1178. [Content Brief]
